TCL Archive Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer January 25, 2008
TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013